Back to search

Ireland· IE-PA-PA1986/052/001

Quinine Sulphate 300 mg film coated tablets

A quinine product containing quinine sulfate, registered in Ireland by Teva B.V.. The same ATC class is registered in 9 of our 19 countries.

ATC P01BC01

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedQuinine Sulphate 300 mg film coated t…ATCP01BC01REGISTER NO.IE-PA-PA1986/052/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Quinine is registered in 9 of 19 countries.

Countries holding a registration under ATC P01BC01 (quinine), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 3 of them publish a price we can compare per daily dose

Quinine · ATC P01BC01

9 / 19 countries

  • Canada
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Quinine sulfate
Manufacturer
Teva B.V.
Country
Ireland (IE)
ATC code
P01BC01
ATC class
Quinine
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA1986/052/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

496 interactions on record for quinine.

Graded by severity as the source publishes them — 102 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Quinine · interactions on record

496 records

  • 102 severe
  • 378 moderate
  • 16 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • Sodium picosulfateA06AB08severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Quinine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All quinine products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Cyprus · Quinine Sulphate Remedica
  • Germany · Chinin Axunio, Chinin Divapharma
  • Denmark · Chininsulfate Axunio
  • France · Quinine Renaudin
  • United Kingdom (Northern Ireland) · Quinine Bisulfate, Quinine Bisulfate Strides Pharma Uk
  • Italy · Chinina Cloridrato Agenzia Industrie Difesa - Stabilimento Chimico Farmaceutico Militare, Chinina Cloridrato Galenica Senese
  • Netherlands · A-Qs 200
  • Portugal · Quinina Labesfal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8605cbed-34c1-49e9-bb16-2c7ac696e65a
GET /v1/drugs/8605cbed-34c1-49e9-bb16-2c7ac696e65a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "P01BC",
    "P01BC01"
  ],
  "strength": null,
  "pa_number": "PA1986/052/001",
  "substances": [
    "Quinine sulfate"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "04/07/1985",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about quinine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.